4 article(s) from Bossmann, Stefan H
Figure 1: Nanosensors for in vitro protease detection. For each protease, a highly selective oligopeptide is ...
Figure 2: Mechanistic scheme of the “light switch effect” upon proteolytic cleavage: the fluorophore is switc...
Figure 3: TEM (1a,1b) and HRTEM (1c) images of Fe/Fe3O4-core/shell nanoparticles that are forming the inorgan...
Figure 4: Matrix effects for MMP7, MMP13, and cathepsin L after 60 min of incubation at 25 °C under standard ...
Figure 5: Matrix effects for MMP1, MMP 2, MMP 3, and cathepsin B after 60 min of incubation at 25 °C under st...
Figure 6: Cross-sensitivities of the nanoplatforms used in this study. Further explanations are provided abov...
Figure 7: Bar graph (left, showing means and standard deviations) and box plot (right, indicating the observe...
Figure 8: Calculated p-values; comparison of breast cancer patients and healthy human subjects for all invest...
Figure 9: Average protease activity as a function of breast cancer stage/healthy control group for all nine p...
Figure 1: GC profile of the products formed during CO2 hydrogenation at different temperatures.
Figure 2: TEM and HRTEM of Fe/Fe3O4 nanoparticles prepared by thermal decomposition of Fe(CO)5 in the presenc...
Figure 3: TEM and HRTEM of Fe/Fe3O4 nanoparticles prepared by thermal decomposition of Fe(CO)5 in the presenc...
Figure 4: XRD patterns of the Fe/Fe3O4 nanoparticles as a function of catalytic run (2 h at 400 °C).
Figure 5: XPS surveys of the catalyst: a) as prepared with HDA synthesis, b) after 5 runs, c) after 10 runs, ...
Figure 6: XPS of the Fe 2p3/2 and Fe 2p1/2 region for the catalyst: a) after 10 runs, b) after 5 runs, c) as ...
Scheme 1: Hydrogenation of carbon suboxide.
Scheme 2: Trimerization of hydrogenated carbon suboxide on Fe3O4.
Scheme 3: Keto–enol tautomerism leads to aromatization.
Scheme 4: Reduction of the intermediate phenol derivative to mesitylene.
Scheme 5: Demethylation is at this stage of mechanistic research the most likely process explaining the forma...
Figure 7: Product selectivities as a function of temperature: blue: 440 °C, yellow: 480 °C, orange: 500 °C, r...
Figure 8: Tubular reactor used in the catalytic reduction reaction.
Figure 1: The structure of the homo-octameric mycobacterial porin MspA. (A) MspA is 9.6 nm in length and 8.8 ...
Figure 2: Hydrodynamic diameter of MspA aggregates as a function of temperature, measured by dynamic light sc...
Figure 3: Geometric calculations based on the crystal structure of MspA [2].
Figure 4: TEM of vesicles formed from MspA on a carbon-coated 200-mesh copper grid. A: MspA vesicles formed i...
Figure 5: Distance between two neighboring MspA octamers in the outer layer of the vesicle’s double layer, an...
Figure 6: Estimated number of MspA-octamers forming a unilamellar vesicle (the presence of one MspA double la...
Figure 7: Zeta potential of MspA aggregates as a function of temperature. Blue: MspA (1.688 × 10−5 mg·mL−1) i...
Scheme 1: Preparation of core/shell Fe/Fe3O4 magnetic nanoparticles (MNPs).
Scheme 2: Functionalization of SN38.
Figure 1: TEM of the core/shell Fe/Fe3O4 nanoparticles: (a) freshly synthesized MNPs; (b) MNP-SN38; (c) HRTEM...
Figure 2: Powder XRD patterns of MNP-SN38.
Figure 3: Fluorescence spectra of MNP-SN38 and free SN38 released from MNP.
Figure 4: Toxicity of MNP-SN38 on double stable Mo/Ma after 24 h of loading; the MTT assay was performed for ...
Figure 5: Double-stable Mo/Ma loaded with MNP-SN38 320 g/mL(medium). a: Prussian blue staining and counter st...
Figure 6: Flow cytometry of MNP-SN38 loaded double-stable Mo/Ma after 24 h. Side scatter was used to measure ...
Figure 7: Iron concentration per double-stable Mo/Ma cell loaded with different concentrations of MNP-SN38.
Scheme 3: RAW264.7 cell (monocyte/macrophage) delivered thermochemotherapy.